Silence Therapeutics plc Deferred Income Tax Expense (Benefit)
Silence Therapeutics plc (SLN) reported Deferred Income Tax Expense (Benefit) of $1.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-08-10
- Silence Therapeutics plc deferred income tax expense (benefit) for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Silence Therapeutics plc deferred income tax expense (benefit) for the quarter ending 2025-09-30 was $1.00K, a 97.96% decline year-over-year.
- Silence Therapeutics plc deferred income tax expense (benefit) for the quarter ending 2025-06-30 was $10.00K, a 95.61% decline year-over-year.
- Silence Therapeutics plc deferred income tax expense (benefit) for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Silence Therapeutics plc deferred income tax expense (benefit) for fiscal 2025 was $11.00K, a 98.70% decline from fiscal 2024.
- Silence Therapeutics plc deferred income tax expense (benefit) for fiscal 2024 was $845.00K, a 11.61% decline from fiscal 2023.
- Silence Therapeutics plc deferred income tax expense (benefit) for fiscal 2023 was $956.00K, a 38.95% increase from fiscal 2022.
- Silence Therapeutics plc deferred income tax expense (benefit) for fiscal 2022 was $688.00K.
| Period end | Deferred Income Tax Expense (Benefit) 3 month | Deferred Income Tax Expense (Benefit) 6 month | Deferred Income Tax Expense (Benefit) 9 month | Deferred Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.00K 10-Q · filed 2026-08-10 | |||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $1.00K derived: sum of 2 quarters · filed 2026-03-05 | $11.00K derived: sum of 3 quarters · filed 2026-08-10 | $11.00K 10-K · filed 2026-03-05 |
| 2025-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $11.00K derived: sum of 2 quarters · filed 2026-08-10 | $11.00K 10-Q · filed 2025-11-06 | $335.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $10.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $10.00K 10-Q · filed 2026-08-10 | $334.00K derived: sum of 3 quarters · filed 2026-08-10 | $383.00K derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-08 | $324.00K derived: sum of 2 quarters · filed 2026-03-05 | $373.00K derived: sum of 3 quarters · filed 2026-03-05 | $601.00K derived: sum of 4 quarters · filed 2026-03-05 |
| 2024-12-31 | $324.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $373.00K derived: sum of 2 quarters · filed 2026-03-05 | $601.00K derived: sum of 3 quarters · filed 2026-03-05 | $845.00K 10-K · filed 2026-03-05 |
| 2024-09-30 | $49.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $277.00K derived: sum of 2 quarters · filed 2025-11-06 | $521.00K 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $228.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $472.00K 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $244.00K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $956.00K 10-K · filed 2025-02-27 | |||
| 2022-12-31 | $688.00K 10-K · filed 2025-02-27 |